Nauka i natura

Creative Biolabs

anti EBNA3C TCR from Creative Biolabs that has expanded to the entire new drug discovery and development pipeline, including early discovery, preclinical testing, process development, cGMP manufacturing, phase 263-III clinical trials. https://www.creative-biolabs.com/car-t/target-ebna3c-37.htm
Momencik, trwa przetwarzanie danych   loading-animation